AUSTIN, Texas, Sept. 18, 2023 /PRNewswire/ -- With cold and flu season underway, Superior HealthPlan, a managed care company that delivers quality health care in Texas and a subsidiary of Centene Corporation, is encouraging Texans to get vaccinated and learn about potential health risks through its annual Fluvention® program. While contracting the flu can be dangerous, the risk of serious illness is higher this year when combined with the threat COVID-19 and respiratory syncytial virus (RSV), collectively known as the "tripledemic."
"Every flu season is unique and, this year, there are concerns with not only the flu, but also with COVID-19 and RSV," said Superior HealthPlan Chief Medical Director Dr. David Harmon. "While it may seem early, it takes two weeks after getting a vaccine for the antibodies that protect against a virus to fully develop, so it's best to act early."
Vaccination is the first step in protecting oneself against all three viruses. Below is more information about each vaccine:
Superior's Fluvention® program offers resources at no cost to help Texans understand the importance of the flu shot, the risks of contracting the flu, and other preventive measures. The initiative strives to increase vaccination rates for the flu and other viruses, especially for high-risk populations, by delivering targeted messaging through direct mail, phone calls, texting, social media, and local events.
For all three viruses, vaccination and practicing good hygiene, like washing hands and covering coughs, are key to prevention. Superior members can receive vaccines at no cost through their doctor or participating pharmacy. While everyone should get vaccinated, the CDC notes it's especially important for the following groups who are at higher risk for complications:
For more information about Superior's Fluvention® program, visit SuperiorHealthPlan.com/flu.
About Superior HealthPlan
Founded in 1999, Superior HealthPlan is a managed care company that delivers quality healthcare throughout Texas. Committed to transforming the health of the community, one person at a time, Superior supports active local involvement in all 254 Texas counties with 3,200 employees throughout the state. Superior is a wholly owned subsidiary of Centene Corporation (NYSE: CNC), a Fortune 26 company that offers affordable and high-quality products to nearly 1 in 15 individuals across the nation. For more information visit www.SuperiorHealthPlan.com.
Last Trade: | US$65.12 |
Daily Change: | 1.59 2.50 |
Daily Volume: | 3,473,641 |
Market Cap: | US$32.880B |
October 30, 2024 October 25, 2024 September 11, 2024 August 29, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load